Riboflavin kinase
Riboflavin kinase is an enzyme that plays a crucial role in the biochemical pathway of vitamin B2 (riboflavin) metabolism. This enzyme catalyzes the phosphorylation of riboflavin to form flavin mononucleotide (FMN), a process that is essential for the utilization of riboflavin by the cell. FMN acts as a cofactor for various oxidoreductase enzymes and is critical for numerous cellular processes, including energy metabolism, cell growth, and development.
Function[edit | edit source]
Riboflavin kinase (EC 2.7.1.26) catalyzes the ATP-dependent phosphorylation of riboflavin to produce FMN, according to the reaction:
ATP + riboflavin → ADP + FMN
This reaction is the first step in the conversion of riboflavin into its active forms, FMN and flavin adenine dinucleotide (FAD), which are essential cofactors for a wide range of enzymatic reactions. The activity of riboflavin kinase is therefore pivotal for the cellular uptake and utilization of riboflavin and for maintaining the cellular redox state.
Structure[edit | edit source]
The structure of riboflavin kinase varies among different species, but it generally consists of a single polypeptide chain that folds into a compact structure. The active site of the enzyme is designed to bind both ATP and riboflavin, facilitating the transfer of a phosphate group. In humans, riboflavin kinase is encoded by the RFK gene, which has been mapped to chromosome 9.
Clinical Significance[edit | edit source]
Alterations in the activity or expression of riboflavin kinase can lead to disturbances in riboflavin metabolism, potentially resulting in cellular dysfunction and disease. Deficiencies in riboflavin kinase activity have been associated with multiple disorders, including certain types of anemia and neurodegenerative diseases. Moreover, since riboflavin is crucial for energy production and antioxidant defense, its proper metabolism is essential for overall health.
Genetic Regulation[edit | edit source]
The expression of the RFK gene, and consequently the activity of riboflavin kinase, is regulated by various transcription factors and microRNAs that respond to the cellular levels of riboflavin and energy status. This ensures that the synthesis of FMN and FAD is matched to the cellular demand for these cofactors.
Pharmacological Aspects[edit | edit source]
Given its central role in riboflavin metabolism, riboflavin kinase has been explored as a potential target for the development of drugs aimed at modulating the cellular levels of FMN and FAD. Such drugs could have therapeutic potential in diseases where disrupted flavin metabolism plays a role.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD